A PYMNTS Company

US: Senate to examine drug prices Tuesday

By  |  February 24, 2019

US drugmaker Merck stated that its CEO Ken Frazier plans to testify at a Senate hearing Tuesday, February 26.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee invited executives from seven pharmaceutical companies, including Merck, to testify. The others are AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, and Sanofi.

    Congress has been targeting the pharmaceutical industry over the rising cost of prescription drugs for US consumers, particularly since Democrats took over the House of Representatives in January.

    Full Content: CT Mirror

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.